Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

NCT01600014 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01600014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
February 28, 2014
Enrollment
463 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis